GV Reddy’s exit evokes mixed response in TDP
VIJAYAWADA: The exit of GV Reddy from AP State FiberNet Limited (APSFL) and his resignation from the TDP primary membership ...
Deccan Chronicle2d
TD leader and FiberNet cairman GV Reddy resigns; government transfers MD Dinesh Kumar
Telugu Desam leader GV Reddy has shocked the party by resigning from his position as chairman of the scandal-hit AP FiberNet ...
GV Prasad of Dr Reddy's says 25% tariff on pharma exports could make medicines costlier for US consumers
GV Prasad, Co-Chairman & Managing Director of Dr Reddy's said the proposed 25% tariff of Trump administration on ...
Third eye: Lobbying for special leadership post, Striking a balance between babus and netas and Subsiding Euphoria
Andhra Pradesh CM N Chandrababu Naidu is dealing with tensions between bureaucrats and party leaders, highlighted by GV Reddy ...
GV Reddy Resigns as AP FiberNet Chairman and TDP Primary Membership
GV Reddy has resigned from his position as the Chairman of AP FiberNet and has also stepped down from the primary membership ...
APSFL chief GV Reddy quits post, TDP
VIJAYAWADA: In a surprising development, Andhra Pradesh State FiberNet Limited Chairman GV Reddy, who created a flutter by disclosing several irregularities in ...
Indian drugmakers likely to stay competitive despite planned tariffs, Dr Reddy's says
Indian drugmakers, including Dr Reddy's, are confident about maintaining competitiveness in the generic drugs market despite ...
Indian drugmakers to stay competitive despite US tariff plans: Dr Reddy's
The industry is still waiting for more clarity on any tariffs before taking any action, Prasad said on the sidelines of the ...
The Financial Express2d
How will Trump’s tariff threat on pharmaceuticals impact Indian drugmakers? Dr Reddy’s reacts
Earlier this month, the US President said that he intends to impose a "25% or higher" levies on semiconductors and ...
Indian drugmakers likely to stay competitive as US tariffs loom, Dr Reddy's says
Indian drugmakers are likely to remain competitive in the generic drugs market in the face of U.S. President Donald Trump's plans to levy tariffs on pharmaceutical imports, Dr Reddy's Managing ...